Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

SI-BONE Inc

SIBN ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Small Cap Analyst: BUY

Last Close

$18.93

▼ -0.11%

Market Cap $848.42M · Vol 87.30K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$848.42M

Small Cap

Div Yield

N/A

EPS Growth

+9.74%

YoY

RSI (14)

71.96

Momentum

Beta

0.71

vs Market

52W High

$21.85

13.36% below

52W Low

$11.48

64.90% above

Volume

87.30K

Avg 188.80K

P/B

4.85

Price-to-book

ROE

-10.97%

Return on equity

Free Float

96.62%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, SI-BONE Inc (SIBN) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SIBN pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.72%

+11.95%

+29.66%

+23.48%

YTD

-4.01%

+23.73%

-11.50%

-9.81%

Financials & Valuation

TTM · Annual

Total Revenue	$200.93M
Net Income	$-18,904,000.00
Revenue Growth (YoY)	+15.18%
Gross Margin	79.57%
Operating Margin	-11.11%
Net Profit Margin	-9.41%
ROE	-10.97%
ROA · ROIC	-8.06% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	4.22
P/B	4.85
P/FCF	N/A
EPS Growth	+9.74%
Outstanding Shares	44.82M

Technical Indicators

50-Day SMA	$17.01
200-Day SMA	$16.16
RSI (14)	71.96
Beta	0.71
52-Week High	$21.85
52-Week Low	$11.48

Volume Today	87.30K
Avg Daily Volume (30D)	188.80K
Relative Volume	0.46x
Volatility (10D)	24.94
Volatility (30D)	36.58
Free Float	96.62%

Analyst Consensus

BUY

Current Price $18.93

Mean Target $24.78

52W Low$11.48 52W High$21.85

Current

Target

$11.48 $21.85

Current Analyst target

+30.89% upside potential · 10 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001V0GNP7

ISINUS8257041090

CountryUnited States of America

Sub-IndustryMedical Equipment

Earnings DateNov 9, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

PEN Penumbra Inc +0.08% GETI B.ST Getinge publ AB +0.08% 7747.T Asahi Intecc Co Ltd -0.97% MMED MiniMed Group Inc +0.65% 688617.SS APT Medical Inc +0.14%

Company Profile

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants, and the instruments used to implant them, as well as implantable bone products. Its products include iFuse, iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite. Within the United States, iFuse, iFuse-3D and iFuse-TORQ have clearances for applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma. Its first-generation iFuse, a machined triangular titanium implant, has a triangular cross section that resists twisting or rotation of the implant. The Company's second generation iFuse product, the iFuse-3D implant, is a patented titanium implant.